SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-438170
Filing Date
2013-11-12
Accepted
2013-11-12 15:49:21
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d606351d10q.htm 10-Q 735034
2 EX-31.1 d606351dex311.htm EX-31.1 8944
3 EX-31.2 d606351dex312.htm EX-31.2 9019
4 EX-32.1 d606351dex321.htm EX-32.1 4838
  Complete submission text file 0001193125-13-438170.txt   5055657

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT arna-20130930.xml EX-101.INS 687592
6 XBRL TAXONOMY EXTENSION SCHEMA arna-20130930.xsd EX-101.SCH 48716
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arna-20130930_cal.xml EX-101.CAL 57097
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arna-20130930_def.xml EX-101.DEF 282151
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20130930_lab.xml EX-101.LAB 391015
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20130930_pre.xml EX-101.PRE 331858
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 131210029
SIC: 2834 Pharmaceutical Preparations